Myelodysplastic/myeloproliferative neoplasm with t(2;11)(p21;q23)del(5) (q22;q33) but without mixed-lineage leukemia (MLL) rearrangement

Myelodysplastic/myeloproliferative neoplasm with t(2;11)(p21;q23)del(5) (q22;q33) but without mixed-lineage leukemia (MLL) rearrangement

Introduction. Myelodysplastic/myeloproliferative neoplasms represent a group of rare hematologic malignancies with concomitant characteristics of two different disorders. There are cytopenias and cytoses with dysplastic morphology in the circulating blood and hyperplastic bone marrow, respectively....

Full description

Bibliographic Details
Main Authors: Čolović Nataša, Denčić-Fekete Marija, Stamatović Dragana, Leković Danijela, Gotić Mirjana
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2021-01-01
Series:Vojnosanitetski Pregled
Subjects:
myelodysplastic syndrome
thrombocytosis
myeloproliferative disorders
janus kinase-2
mutation
antineoplastic agents
lenalidomide
treatment outcome
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84501900011C.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84501900011C.pdf

Similar Items